文献速递创伤骨科骨质疏松与代谢性骨病

血液与骨源性DNA甲基化年龄可预测老年髋部骨折后死亡率:一项先导研究

Blood and Bone-Derived DNA Methylation Ages Predict Mortality After Geriatric Hip Fracture: A Pilot Study.
PubMed 文献 · J Bone Joint Surg Am · 2024-11-07

该先导研究前瞻性纳入2020至2021年65岁及以上髋部骨折患者,采集术前全血与术中骨样本行DNA甲基化时钟分析。12例受试者中,死亡组骨与血甲基化年龄差均显著高于存活组,骨与血甲基化年龄强相关(R=0.81)。作者认为骨源性DNA甲基化时钟可行,甲基化年龄与死亡率独立相关。

要点

  • 骨与血DNA甲基化年龄强相关(R=0.81;p=0.0016)。
  • 死亡组ΔAgeBone 18.33±6.47年、ΔAgeBlood 16.93±4.02年,均显著高于存活组。
  • 死亡组甲基化年龄约比实际年龄大17年。

核心结论

  • 骨源性DNA甲基化时钟可行,且与全血来源的甲基化时钟强相关(R=0.81;p=0.0016)。
  • 在老年髋部骨折人群中,死亡率与DNA甲基化年龄独立相关,死亡队列中甲基化年龄约比实际年龄大17年。
  • 作者认为预防晚期DNA甲基化可能在降低髋部骨折后死亡率中起关键作用。

研究设计与样本

  • 前瞻性纳入2020至2021年就诊于一级创伤中心的65岁及以上髋部骨折患者。
  • 采集术前全血与术中骨样本,行DNA提取及RRBS(简化代表性亚硫酸氢盐测序)文库制备以分析甲基化时钟。
  • 采用Horvath等先前描述的计算算法为每种组织类型构建甲基化(生物学)年龄回归模型。
  • 使用Student t检验分析甲基化年龄与实际年龄的差值(Δ),用Pearson R系数表达血与骨甲基化年龄的相关性。

主要发现

  • 共47例患者采集血与骨样本;对来自12名受试者的24份标本完成DNA提取、测序和甲基化分析。
  • 就诊时平均年龄85.4±8.65岁,平均随访12.4±4.3个月。
  • 血与骨样本的DNA提取产量无差异(p=0.935)。
  • 死亡队列(4例,33%)平均ΔAgeBone为18.33±6.47年、平均ΔAgeBlood为16.93±4.02年。
  • 存活队列平均ΔAgeBone与ΔAgeBlood显著更低(分别为7.86±6.7年与7.31±7.71年;p=0.026与0.039)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to (1) perform the first analysis of bone-derived DNA methylation, (2) compare DNA methylation clocks derived from bone with those derived from whole blood, and (3) establish a relationship between DNA methylation age and 1-year mortality within the geriatric hip fracture population. METHODS: Patients ≥65 years old who presented to a Level-I trauma center with a hip fracture were prospectively enrolled from 2020 to 2021. Preoperative whole blood and intraoperative bone samples were collected. Following DNA extraction, RRBS (reduced representation bisulfite sequencing) libraries for methylation clock analysis were prepared. Sequencing data were analyzed using computational algorithms previously described by Horvath et al. to build a regression model of methylation (biological) age for each tissue type. Student t tests were used to analyze differences (Δ) in methylation age versus chronological age. Correlation between blood and bone methylation ages was expressed using the Pearson R coefficient. RESULTS: Blood and bone samples were collected from 47 patients. DNA extraction, sequencing, and methylation analysis were performed on 24 specimens from 12 subjects. Mean age at presentation was 85.4 ± 8.65 years. There was no difference in DNA extraction yield between the blood and bone samples (p = 0.935). The mean follow-up duration was 12.4 ± 4.3 months. The mortality cohort (4 patients, 33%) showed a mean ΔAgeBone of 18.33 ± 6.47 years and mean ΔAgeBlood of 16.93 ± 4.02 years. In comparison, the survival cohort showed a significantly lower mean ΔAgeBone and ΔAgeBlood (7.86 ± 6.7 and 7.31 ± 7.71 years; p = 0.026 and 0.039, respectively). Bone-derived methylation age was strongly correlated with blood-derived methylation age (R = 0.81; p = 0.0016). CONCLUSIONS: Bone-derived DNA methylation clocks were found to be both feasible and strongly correlated with those derived from whole blood within a geriatric hip fracture population. Mortality was independently associated with the DNA methylation age, and that age was approximately 17 years greater than chronological age in the mortality cohort. The results of the present study suggest that prevention of advanced DNA methylation may play a key role in decreasing mortality following hip fracture. LEVEL OF EVIDENCE: Prognostic Level I . See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Tarpada SP, Heid J, Sun S, et al. Blood and Bone-Derived DNA Methylation Ages Predict Mortality After Geriatric Hip Fracture: A Pilot Study. J Bone Joint Surg Am. 2024. PMID: 39509524. doi:10.2106/JBJS.23.01468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。